OptiBiotix Health PLC Director's Dealing

Fecha : 28/08/2019 @ 04:00
Fuente : UK Regulatory (RNS & others)
Emisora : Optibiotix Health Plc (OPTI)
Cotización : 65.0  -1.5 (-2.26%) @ 05:18
Optibiotix Health Cotización de acciones Gráfica

OptiBiotix Health PLC Director's Dealing

Optibiotix Health (LSE:OPTI)
Gráfica de Acción Histórica

De May 2019 a May 2020

Haga Click aquí para más Gráficas Optibiotix Health.


RNS Number : 3997K

OptiBiotix Health PLC

28 August 2019

28 August 2019

OptiBiotix Health plc

("OptiBiotix" or the "Company")

Director's Dealing

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it received notification today that Frédéric Narbel, a Director of the Company, acquired 17,000 ordinary shares in the Company today, representing 0.02% of the Company's issued share capital, at a price of 50 pence per share.

Following the transaction, Mr Narbel is interested in 29,000 ordinary shares in the Company, representing 0.03% of the Company's issued share capital.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 and the person who arranged for release of this announcement on behalf of the Company was Stephen O'Hara, Chief Executive.

For further information, please contact:

 OptiBiotix Health plc                                  www.optibiotix.com 
 Stephen O'Hara, Chief Executive                      Contact via Walbrook 
 Cairn Financial Advisers LLP (NOMAD)                   Tel: 020 7213 0880 
 Liam Murray / Jo Turner / Ludovico Lazzaretti 
 finnCap (Broker)                                       Tel: 020 7220 0500 
 Geoff Nash / Kate Bannatyne (Corporate Finance) 
 Camille Gochez (Corporate Broking) 
 goetzpartners securities Limited                       Tel: 0203 859 7725 
 Ulrich Kinzel 
 Walbrook PR Ltd                                        Mob: 07876 741 001 
 Anna Dunphy 

About OptiBiotix - www.optibiotix.com

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D program working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.

 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1       Details of the person discharging managerial responsibilities/person 
          closely associated 
 a.      Name                                     Frédéric André Narbel 
        ---------------------------------------  ------------------------------------------------ 
 2       Reason for notification 
        ---------------------------------------  ------------------------------------------------ 
 a.      Position/Status                          Director of the Company 
        ---------------------------------------  ------------------------------------------------ 
 b.      Initial notification/                    Initial Notification 
        ---------------------------------------  ------------------------------------------------ 
 3       Details of the issuer, emission allowance market participant, 
          auction platform, auctioneer or auction monitor 
 a.      Name                                     OptiBiotix Health Plc 
        ---------------------------------------  ------------------------------------------------ 
 b.      LEI                                      213800UKYQFT941QHS14 
        ---------------------------------------  ------------------------------------------------ 
 4       Details of the transaction(s): section to be repeated for 
          (i) each type of instrument; (ii) each type of transaction; 
          (iii) each date; and (iv) each place where transactions have 
          been conducted 
 a.      Description of                           17,000 ordinary shares of 2p each 
          the financial 
          instrument, type 
          of instrument 
                                                   ISIN: GB00BP0RTP38 
        ---------------------------------------  ------------------------------------------------ 
 b.      Nature of the                            Purchase of 17,000 ordinary shares in the 
          transaction                              Company 
        ---------------------------------------  ------------------------------------------------ 
 c.      Price(s) and volume(s)                    Price(s) per               Volume(s) 
        ---------------------------------------   ------------------------- 
                                                   50p                        17,000 
                                                  -------------------------  ----------------- 
 e.      Date of the transaction                  28 August 2019 
        ---------------------------------------  ------------------------------------------------ 
 f.      Place of the transaction                 London Stock Exchange, AIM 
        ---------------------------------------  ------------------------------------------------ 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.



(END) Dow Jones Newswires

August 28, 2019 05:00 ET (09:00 GMT)

Su Consulta Reciente
Fibra Prol..
América Mó..
IPC México
United Sta..
Las acciones que ha visto aparecerán en este recuadro, lo que le permite volver fácilmente a las cotizaciones que ha consultado previamente
Registrarse ahora para crear su lista personalizada de acciones en streaming.

Cotizaciones PLUS están en tiempo real. Cotizaciones NYSE y AMEX están con retraso de por lo menos 20 minutos.
El resto de las cotizaciones están con retraso de por lo menos 15 minutos al menos que se indique lo contrario.

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

P: V:mx D:20200528 02:19:47